Gary Stevenson co-founded MB Venture Partners in 2001 after six years in health care investment banking and research. He also spent seven years in a variety of general management roles with Abbott Laboratories, one of the largest and most diversified health care companies in the world. Gary holds an undergraduate degree in accounting from the University of Missouri. He also received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University. He is a certified public accountant and a chartered financial analyst. Gary is a board member or observer for several MBVP portfolio companies including AxioMed Spine, BioSET, Kereos, KFx Medical, Hapten Sciences, S2 Interactive, Visioneering, Focal Point Pharmaceuticals, iScreen, Restore Medical Solutions, MB Innovations, EcoSurg, View Medical, Better Walk, Camplex, and CrossRoads. Gary also serves on the board of Life Science Tennessee and ZeroTo510.